Does TRIAMTERENE Cause Focal segmental glomerulosclerosis? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Focal segmental glomerulosclerosis have been filed in association with TRIAMTERENE (Triamterene). This represents 3.8% of all adverse event reports for TRIAMTERENE.
13
Reports of Focal segmental glomerulosclerosis with TRIAMTERENE
3.8%
of all TRIAMTERENE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From TRIAMTERENE?
Of the 13 reports, 4 (30.8%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIAMTERENE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does TRIAMTERENE Cause?
Coma (60)
Gastrooesophageal reflux disease (60)
Pneumonia aspiration (60)
Somnolence (60)
Underdose (39)
Drug hypersensitivity (37)
Off label use (28)
Completed suicide (25)
Drug ineffective (23)
Lymphopenia (22)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which TRIAMTERENE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
TRIAMTERENE vs TRIATEC
TRIAMTERENE vs TRIAZOLAM
TRIAMTERENE vs TRICHLORMETHIAZIDE
TRIAMTERENE vs TRICLOSAN
TRIAMTERENE vs TRIENTINE